Safety and Effectiveness of Midline CathetersVascular Access Devices
Investigational drug(s) / intervention(s)
Midline catheter placement
Midline catheter placement: Patients receive a midline catheter as part of their routine clinical care for intravenous therapy lasting 1 to 4 weeks
Study summary
The goal of this observational study is to learn about the safety and effectiveness of midline catheters in patients who receive midline catheter placement as part of their routine clinical care. The main question it aims to answer is:
Do midline catheters demonstrate acceptable safety and effectiveness when used in routine clinical practice?
Participants who receive a midline catheter as part of their regular medical care will have their clinical data collected from electronic medical records and patient questionnaires, and followed for outcomes related to catheter-related complications and functional performance.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Age ≥ 18 years
* First-time midline catheter placement per physician order
* Not enrolled in another clinical study
* Willing and able to provide informed consent and comply with follow-up (unless consent waived by local ethics committee)
Exclusion Criteria:
* Deemed unsuitable by investigator (e.g., poor compliance or inability to communicate clearly)
* Refusal of informed consent by patient or family member
Primary outcome measure(s)
Number of Participants With Catheter-Related Complications — From catheter insertion until removal, assessed up to 28 days Catheter-related complications include phlebitis, catheter-related bloodstream infection (CRBSI), venous thrombosis, and catheter occlusion. Complication rate is calculated as the number of participants experiencing at least one complication divided by the total number of enrolled participants, multiplied by 100 percent.
Trial sites (1)
Facility
City
Region
Status
Zibo Central Hospital
Zibo
China
Recruiting
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.